These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 9434484

  • 1. [Clinical aspects of Insulin Lispro (LY275585)].
    Kuzuya T.
    Nihon Rinsho; 1997 Nov; 55 Suppl():298-305. PubMed ID: 9434484
    [No Abstract] [Full Text] [Related]

  • 2. [Taking the peak out of blood pressure. Diabetics can also live spontaneously].
    MMW Fortschr Med; 1999 Dec 09; 141(49-50):66-7. PubMed ID: 10726151
    [No Abstract] [Full Text] [Related]

  • 3. Updating the insulin lispro file.
    Grossman LD.
    CMAJ; 1998 May 05; 158(9):1132-3. PubMed ID: 9597962
    [No Abstract] [Full Text] [Related]

  • 4. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr 14; 153(15):44-5. PubMed ID: 21667560
    [No Abstract] [Full Text] [Related]

  • 5. [Intensified therapy with insulin analogs in type 2 diabetes: normalizing metabolism and maintaining body weight?].
    Jungmann E, Helling T, Jungmann G, Mertens C, Snelting U.
    MMW Fortschr Med; 2000 Oct 26; 142(43):48. PubMed ID: 11098614
    [No Abstract] [Full Text] [Related]

  • 6. Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group.
    Roach P, Trautmann M, Arora V, Sun B, Anderson JH.
    Clin Ther; 1999 Mar 26; 21(3):523-34. PubMed ID: 10321421
    [Abstract] [Full Text] [Related]

  • 7. Insulin lispro (Humalog), a novel fast-acting insulin analogue: guidelines for its practical use.
    Nobels FR, Hermans MP, De Leeuw I.
    Acta Clin Belg; 1999 Oct 26; 54(5):246-54. PubMed ID: 10555382
    [No Abstract] [Full Text] [Related]

  • 8. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
    Lepore G, Dodesini AR, Nosari I, Trevisan R.
    Diabetes Care; 2003 Apr 26; 26(4):1321-2. PubMed ID: 12663625
    [No Abstract] [Full Text] [Related]

  • 9. Intensifying insulin therapy with insulin analog premixes: transitioning from basal insulin in type 2 diabetes.
    Shanik MH.
    Diabetes Technol Ther; 2012 Jun 26; 14(6):533-9. PubMed ID: 22364142
    [Abstract] [Full Text] [Related]

  • 10. [Insulin lispro].
    Matsuda A.
    Nihon Rinsho; 2001 Nov 26; 59(11):2140-3. PubMed ID: 11712398
    [Abstract] [Full Text] [Related]

  • 11. [HbA1c is too high despite tablets. With single injections toward better blood glucose values].
    MMW Fortschr Med; 2004 Mar 04; 146(10):43. PubMed ID: 15347083
    [No Abstract] [Full Text] [Related]

  • 12. Impaired absorption of insulin aspart from lipohypertrophic injection sites.
    Johansson UB, Amsberg S, Hannerz L, Wredling R, Adamson U, Arnqvist HJ, Lins PE.
    Diabetes Care; 2005 Aug 04; 28(8):2025-7. PubMed ID: 16043749
    [No Abstract] [Full Text] [Related]

  • 13. Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.
    Becker RH, Frick AD, Nosek L, Heinemann L, Rave K.
    Diabetes Care; 2007 Oct 04; 30(10):2506-7. PubMed ID: 17675541
    [No Abstract] [Full Text] [Related]

  • 14. Improved glycaemic control with the use of self-prepared mixtures of insulin lispro and insulin lispro protamine suspension in patients with types 1 and 2 diabetes.
    Roach P, Strack T, Arora V, Zhao Z.
    Int J Clin Pract; 2001 Apr 04; 55(3):177-82. PubMed ID: 11351771
    [Abstract] [Full Text] [Related]

  • 15. [Control of diabetes mellitus].
    Daweke H.
    Verh Dtsch Ges Inn Med; 1990 Apr 04; 96():175-82. PubMed ID: 2092437
    [No Abstract] [Full Text] [Related]

  • 16. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
    Roach P, Woodworth JR.
    Clin Pharmacokinet; 2002 Apr 04; 41(13):1043-57. PubMed ID: 12403642
    [Abstract] [Full Text] [Related]

  • 17. Should the target A1C level be less than 7 percent? Yes: This should be the target for most patients.
    Peterson K.
    Am Fam Physician; 2012 Dec 15; 86(12):1-2. PubMed ID: 23316992
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Insulin lispro].
    Matsuda A.
    Nihon Rinsho; 2002 Sep 15; 60 Suppl 9():485-91. PubMed ID: 12387039
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.